Legend Biotech

LEGN

23.4003.82% ( +0.860 )

Closed: Nov 6, 16:00:00 (EDT)

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Legend Biotech(LEGN) the Revenue is 387.5 M (+51.93%), Beat estimate;the EBIT is 58 M (+148.5%), Beat estimate;the EPS is 0.18 (+126.5%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.39B51.93%

0.35B37.91%

+0.04B14.02%

EBITExceed expectations

0.06B148.50%

0.02B117.53%

+0.04B30.97%

EPSMiss expectations

0.18126.47%

0.2537137.31%

-0.073710.84%

Upcoming earnings report - Q3 FY2026

Available dateNov 10, 2026

Estimate Revenue$359.91 M

Estimate EBIT-$4.246 M

Estimate EPS$0.0118

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly